Highlights
The paper considers imbalance classification, feature selection, and sample weight in the same framework.
This is the first study simultaneously detecting the severe cases and predicting the conversion time for early diagnosis of COVID-19.
In the early diagnosis of the Coronavirus disease (COVID-19), it is of great importance for either distinguishing severe cases from mild cases or predicting the conversion time that mild cases would possibly convert to severe cases. This study investigates both of them in a unified framework by exploring the problems such as slight appearance difference between mild cases and severe cases, the interpretability, the High Dimension and Low Sample Size (HDLSS) data, and the class imbalance. To this end, the proposed framework includes three steps: (1) feature extraction which first conducts the hierarchical segmentation on the chest Computed Tomography (CT) image data and then extracts multi-modality handcrafted features for each segment, aiming at capturing the slight appearance difference from different perspectives; (2) data augmentation which employs the over-sampling technique to augment the number of samples corresponding to the minority classes, aiming at investigating the class imbalance problem; and (3) joint construction of classification and regression by proposing a novel Multi-task Multi-modality Support Vector Machine (MM-SVM) method to solve the issue of the HDLSS data and achieve the interpretability. Experimental analysis on two synthetic and one real COVID-19 data set demonstrated that our proposed framework outperformed six state-of-the-art methods in terms of binary classification and regression performance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.